The occurrence of gluten sensitivity enteropathy in dermatitis herpetiformis (DH) is now well recognized. We believe that DH is a specific disease entity in which gluten plays a central role in the pathogenesis of both the gut and the skin lesions, and that there is a specific treatmenta gluten-free diet (GFD). Although a GFD is a harmless treatment compared with other therapeutic measures meted out by doctors, it is a considerable social handicap, and the diet must be strict to be effective. At the present time, it must be considered to be life long. Hence, if this form of therapy is to be considered, as indeed it must, one must be absolutely certain in establishing the correct diagnosis before starting on it. In our opinion present criteria, i.e. clinical and histological features and clearance of the rash with dapsone and relapse on withdrawal of this drug, are not precise enough. We know of many patients who have been misdiagnosed as having DH when only these criteria have been used.
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At the present time there is considerable interest among dermatologists, gastroenterologists, geneticists, hmmatologists and immunologists in this disorder. All these groups of workers rely on the dermatologists to make the diagnosis. If the diagnosis is wrong, even in a small percentage, then the results obtained by the investigations will be misleading.
With these points in mind, and the necessity of defining certain strict and rigid criteria, we report here the findings in a group of 58 patients seen over a period of six years in whom the diagnosis of dermatitis herpetiformis was made by 9 consultant dermatologists, and review the efficacy of various criteria in the diagnosis of the disorder.
Of these 58 patients, the diagnosis of DH was finally substantiated in 45 (the DH group) and not substantiated in 13 (non-DH group). Six main diagnostic criteria were considered:
(1) Clinical Features Forty-seven of the 58 patients were seen by a consultant dermatologist at their first visit. In the DH group only 12 (36%) of 34 patients were diagnosed at the first consultation. In the non-DH group, the diagnosis was made in 5 (38%) of 13 patients.
(2) Clearance ofRash with Dapsone or Sulphapyridine In all 45 patients with substantiated DH the skin rash cleared on therapy with dapsone or sulpha-pyridine. On withdrawal of therapy there was relapse in all 45. In the non-DH group, 9 (70 %) of the 13 patients showed similar responses and relapses.
(3) Histology This was graded according to the histological features considered to be characteristic of DH: subepidermal blisters, infiltration with eosinophils and papillary microabscesses. A biopsy showing all three features was scored + + +, two features + +, one only + and none 0.
Of the 58 patients seen, only 30 (52 %.) had had skin biopsies. Of 21 in the DH group, 5 (24%) had all three + + + histological features, 5 (24%) had + +, 10 (47%/O) +, and 1 (5 %) no characteristic features. In the 9 from the non-DH group, none had + + +, 2 (22%) had + +, 6 (66%) had +, and 1 (12%) had none.
(4) IgA in Skin This was looked for by direct immunofluorescence in clinically uninvolved skin, irrespective of whether or not skin lesions were present or the patient was receiving therapy (dapsone or sulphapyridine).
All 37 patients (100%) investigated in the DH group had IgA deposits (Fig 1) in the dermal papilla. None of the 13 patients investigated in the non-DH group had IgA deposits. scopically), 8 had leaves only, and 15 had fingers and leaves. In the non-DH group all the biopsies were normal macroscopically -1 leaves only, and 7 fingers and leaves. Microscopic appearance and lymphocyte count: The number of intraepithelial lymphocytes per 1000 small intestinal epithelial cells was quantitated microscopically. In the DH group the mean numbers of lymphocytes were as follows: flat biopsies 451 (s.e. mean 70, range 313-627); convoluted biopsies 435 (s.e. mean 88, range 130-739); leaves only biopsies 502 (s.e. mean 44, range 404-727); and fingers and leaves biopsies 300 (s.e. mean 50, range 89-422). The count was below 200 in only 2 patients, one of whom had an intestinal lymphoma. Statistically, there was no significant difference between the lymphocyte counts in these four groups. However, compared to a control group of 11 patients with no evidence of small bowel enteropathy (mean 139, s.e. mean 14, range 65-235), the difference is highly significant (P<0.001). The mean in the 8 biopsies in the non-DH group was 151 (s.e. mean 21, range 66-235), only 1 (8%) having a count over 200. There was no significant difference between the lymphocyte counts in the controls and the non-DH group. Taking 200 lymphocytes per 1000 epithelial cells as the upper limit of normal, these findings indicate that the majority (95%) of the DH patients have evidence of enteropathy microscopically compared to 1 (8%) in the non-DH group.
(6) Folate Status Serum folate and red blood cell folate were estimated in 44 patients in the DH group and in all 13 patients in the non-DH group. In the DH group 33 (75%) had low serum levels and 15 (38 %) had low red cell folate levels. In the non-DH group 5 (35%) had low serum levels but none had low red blood cell folate levels.
Conclusions
The findings (Table 1) show that, relying on clinical features, the diagnosis of DH will be inaccurateonly 36 % of our patients were diagnosed at the first visit in the DH group. This is no different from the incidence of diagnosis at their first attendance of the non-DH group (38 %). Similarly, histological findings are not always helpful in establishing the diagnosis with any certainty; a significant number of the biopsies in the non-DH group show features which have for long been considered characteristic of DH. The response of the skin rash to dapsone or sulphapyridine is a useful guide to diagnosing DHall our DH patients' skin rashes cleared on commencing therapy. However, 70% of the patients (1), subcorneal pustular dermatosis (1), vasculitis (1), 'juvenile DH' (1), eczema (2) and undiagnosed (7). Serum folate levels are possibly a useful pointer, but are certainly not diagnostic. Seventy-five per cent of the DH group have low levels, but 38 % of the non-DH group also had low levels. Low red blood cell folate levels are only found in the DH group, but the incidence (35%o) is not sufficiently high for it to be considered a good diagnostic criterion. In contrast, the small intestinal intraepithelial lymphocyte count and the presence of IgA in dermal papille in uninvolved skin appear to be the most reliable diagnostic criteria, for high incidences are found in DH patients and not in the non-DH group (Table 1) . It would appear that the presence of IgA in the dermis is the best criterion, from both the diagnostic and practical points of view. It is found in 100% of DH patients, and uninvolved skin can be used, irrespective of whether or not the patient is receiving therapy or clinical lesions are present. IgA in the dermis in the uninvolved skin has not been described to date in any other condition, and certainly not in any of the other bullous disorders. JThe results of this study will be reported in greater detail elsewhere.
